Добро пожаловать
Нажатие «Авторизоваться» означает, что вы соглашаетесь с Условия использования и политика конфиденциальности Cointime.
Зарегистрировать аккаунт
Аккаунт уже существует?
Нажатие «page.Sign up» означает, что вы соглашаетесь с <a class="underline" href="#term-of-service">Условия использования</a> и a class="underline" href="#privacy-policy">политика конфиденциальности</a> Cointime.
Войдите, используя email
Зарегистрируйтесь с помощью email
твой почтовый ящик
Проверь свои входящие
Нажмите на ссылку в , чтобы войти.
Нажмите на ссылку в , чтобы зарегистрироваться.
AbbVie
company
About
AbbVie is a pharmaceutical company that discovers, develops, and markets both biopharmaceuticals and small molecule drugs.
- 10001 - max
Highlights
Details
- Industries
- Biotechnology,Health Care,Medical,Pharmaceutical
- Founded date
- Jan 1, 2013
- Number Of Employee
- 10001 - max
- Operating Status
- Active
AbbVie is a global, research-based biopharmaceutical company formed in 2013 following separation from Abbott. The company's mission is to use its expertise, dedicated people and unique approach to innovation to develop and market advanced therapies that address some of the world's most complex and serious diseases. In 2013, AbbVie employs approximately 21,000 people worldwide and markets medicines in more than 170 countries.
Investments
Number of Investments
Number of Lead Investments
2
1
AbbVie has made 2 investments. Their most recent investment was on
Sep 21, 2022, when Carisma Therapeutics raised $30M.
|
Date
Company Name
|
Round | Money Raised | Industry | Lead Investor |
|---|---|---|---|---|
|
Sep 21, 2022
Carisma Therapeutics
|
Series C | $30M | Biotechnology | — |
|
Apr 25, 2017
Aquinnah Pharmaceuticals
|
Series Unknown | $10M | Health Care | Yes |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
